Spotting A Winner: Pasithea Therapeutics Corp (NASDAQ: KTTA) Advances 52.15 And It Still Have Room To Run

Pasithea Therapeutics Corp (NASDAQ:KTTA) currently has a daily average trading volume of 17.54K but it saw 56736554 shares traded in last market. With a market cap of 6.08M USD, the company’s current market price of $5.85 came rising about 52.15 while comparing to the previous closing price of $3.85. In past 52 weeks, the stock remained buoying in the range of price level as high as $17.40 and as low as $3.61. In the recent trading on the day, stock has struck highest price mark of $5.3606 while lowest mark touched by it was $7.49.

Taking a look at 20-day trading activity of Pasithea Therapeutics Corp (KTTA) gives us an average price of $4.41, while its current price level is -66.38% below from 52-week high level whereas it is 62.05% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $4.77 while that of 200 days or SMA-200 reads an average of $6.27. A closer look into the stock’s movement over the week reveals that its volatility is standing at 16.82% during that period while stretching the period over a month that decreases to 13.11%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 62.10 which implies that the stock is in neutral territory.

Over the week, KTTA’s stock price is moving 21.87% up while it is 26.90% when we observe its performance for the past one month. Year-to-date it is -20.95% down and over the past year, the stock is showing a downside performance of -43.75%.

Currently, Pasithea Therapeutics Corp’s total number of outstanding shares is 1.04M. Company’s return on investment (ROI) stands at -101.31% and return on equity (ROE) at -63.25%. Stock’s beta reads 0.74. Stock has a price to book (P/B) ratio of 0.38. Its return on asset (ROA) is -58.66% on average.